Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayDec 16, 2016 2:14 pm

NetworkNewsBreaks – National Waste Management Holdings (NWMH) Tackles Ever-Growing Electronic Waste

With technology advancing by the minute, everyone is after a newer, more up-to-date model of their phone, computer, laptop, or other device. Where their old device ends up isn’t something most people worry about. Luckily, there are companies who handle e-waste. “Since the dawn of the electronic and digital ages, varieties of electronic waste (e-waste), which include computers and associated devices and materials, have multiplied. This mountain of waste poses a troubling challenge to the health of the planet and its inhabitants. Thankfully, it is a challenge that has been taken on by Florida-based National Waste Management Holdings (OTC: NWMH).…

Continue Reading

FridayDec 16, 2016 2:13 pm

NetworkNewsBreaks – LightPath Technologies, Inc. (NASDAQ: LPTH) Prices Public Offering of 7M Shares of Class A Common Stock

Shares of LightPath Technologies (NASDAQ: LPTH) are higher this morning after the company priced its underwritten public offering of seven million shares of its Class A common stock at a price of $1.21 per share. It also granted to the underwriters a 45-day option to acquire an additional one million shares to cover over-allotments in connection with the offering, of which the opportunity to acquire 300,000 shares has been exercised. The company expects to use the anticipated $8.15 million proceeds of the offering toward its acquisition of ISP Optics Corporation. The offering is expected to close December 21, 2016. To…

Continue Reading

FridayDec 16, 2016 2:09 pm

NetworkNewsBreaks – GainClients (GCLT) Exclusive HomeSearch Platform Delivers Custom Results to Consumers

Potential home owners generally know what they want in a new home and don’t want to waste time looking at houses that don’t meet their needs. With the new HomeSearch platform from GainClients, homebuyers can save time and energy by essentially eliminating homes that don’t fit their search criteria.  “With this growing demand and a consistently smaller inventory, finding the right home will become more difficult than ever. GainClients, Inc. (OTC: GCLT), a leading provider of technology solutions for the real estate industry, aims at helping consumers look for and identify the right home for them via a comprehensive yet…

Continue Reading

ThursdayDec 15, 2016 1:25 pm

NetworkNewsBreaks – Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Resolves Patent Litigation Regarding Schizophrenia Treatment

Vanda Pharmaceuticals (NASDAQ: VNDA) recently resolved its patent litigation against Apotex regarding Apotex's Abbreviated New Drug Application seeking approval of its generic version of Vanda's Fanapt® (iloperidone). Under a licensing agreement, Vanda has granted Apotex a non-exclusive license to manufacture and commercialize its version of Fanapt® in the U.S., effective November 2, 2027. Fanapt® in 2009 was approved by the FDA for the treatment of schizophrenia in adults. In 2012, the drug was approved for marketing in Israel and Argentina. To view the full press release, visit: http://nnw.fm/XSt0U About Vanda Pharmaceuticals Inc. Vanda is a specialty pharmaceutical company focused on…

Continue Reading

ThursdayDec 15, 2016 1:21 pm

NetworkNewsBreaks – Ocera Therapeutics, Inc. (NASDAQ: OCRX) Targets Hepatic Encephalopathy, a Complication of Liver Cirrhosis, with OCR-002

Ocera Therapeutics (NASDAQ: OCRX) is focused on the development of OCR-002 (ornithine phenylacetate) to treat hyperammonemia and subsequent hepatic encephalopathy (HE). An estimated eight million people in the U.S. suffer from chronic liver disease and approximately one million suffer from liver cirrhosis. HE is a debilitating and progressive complication of liver cirrhosis or liver failure marked by mental changes including confusion, impaired motor skills, and disorientation. Severe HE can cause stupor, coma and even death. Currently, there are no drug treatments that can be given intravenously to hospitalized patients with acute HE. To learn more visit www.ocerainc.com About Ocera Ocera…

Continue Reading

ThursdayDec 15, 2016 1:18 pm

NetworkNewsBreaks – CytoDyn Inc. (CYDY) Advances Clinical Trials for PRO 140 for HIV Infection

Cytodyn (OTCQB: CYDY) is focused on enhancing the lives of people with infectious diseases through the development of new antibody treatments to battle human immunodeficiency virus (HIV) infection. An estimated 1.2 million people in the United States were living with HIV at the end of 2013, the most recent year for which this information is available. Cytodyn recently reported the first several patients have been treated in its phase 3 clinical trial with PRO 140, its proprietary drug that can significantly reduce viral burden in people infected with HIV. PRO 140 works by blocking the HIV co-receptor CCR5 on T-cells…

Continue Reading

WednesdayDec 14, 2016 1:58 pm

NetworkNewsBreaks – Vericel (NASDAQ: VCEL) Receives FDA Approval for MACI®; Shares Soar

Shares of Vericel Corp. (NASDAQ: VCEL) are up more than 60% mid-day after the company broke news of the approval of MACI® (autologous cultured chondrocytes on porcine collagen membrane) by the U.S. Food and Drug Administration (FDA) for the repair of symptomatic single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. MACI is the first FDA-approved cellularized scaffold product that applies tissue engineering processes to grow cells on scaffolds using healthy cartilage tissue from the patient’s own knee. "We believe that the introduction of MACI, along with investments to expand our commercial organization…

Continue Reading

TuesdayDec 13, 2016 2:44 pm

NetworkNewsBreaks – Achaogen, Inc. (AKAO) Proposes Common Stock Public Offering, Proceeds to Advance Plazomicin

Achaogen (NASDAQ: AKAO) has initiated an underwritten public offering of up to 5,750,000 shares of its common stock, all of which are offered by the company. Additionally, Achaogen expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 862,500 shares of common stock at the public offering price, less underwriting discounts and commissions. The company said it intends to use the net proceeds to fund the ongoing development and preparation for potential commercialization of its lead candidate plazomicin, for which the company yesterday announced positive results in phase 3 cUTI and CRE clinical…

Continue Reading

TuesdayDec 13, 2016 2:06 pm

NetworkNewsBreaks – MJP International (MJPI) Takes Aim at “Burgeoning” Texas Market with New Distribution Agreement

Shares of MJP International (OTC: MJPI) are climbing in morning trade after the green products and services company announced its distribution agreement with Texas-based O.C Construction. Per the agreement, O.C Construction will have the exclusive rights to sell and distribute MJP’s products – including different types of wind turbine and solar panels - in parts of Texas. "Over $372 million dollars was invested on solar installations in Texas in 2015. Installed solar capacity in Texas has grown by 65% over the last year. We believe that there is great potential in the Texas market for growth and we will strive…

Continue Reading

TuesdayDec 13, 2016 2:04 pm

NetworkNewsBreaks – Moxian (MOXC) Marketing Solutions Amp-up O2O Commerce

The Online-to-Offline (O2O) market is increasingly desirable to merchants in many industries. Drawing potential customers from online browsing and into a physical store, however, takes strategy. Moxian, Inc. (NASDAQ: MOXC) has created an O2O platform to improve the consumer to merchant connection, enabling businesses to better market and advertise online and potentially attract them to an in-store purchase. “Moxian’s O2O platform targets small- and medium-sized enterprises, including traditional brick-and-mortar vendors, being designed to help them connect with prospects and customers at a deeper level. By integrating social media features, entertainment and gamification, and business intelligence capabilities, the Multi-Channel Social Commerce…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000